Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN

Bibliographic Details
Title: Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
Authors: Ajay K. Nooka, Jonathan L. Kaufman, Cesar Rodriguez, Andrzej Jakubowiak, Yvonne Efebera, Brandi Reeves, Tanya Wildes, Sarah A. Holstein, Larry D. Anderson, Ashraf Badros, Leyla Shune, Ajai Chari, Huiling Pei, Annelore Cortoos, Sharmila Patel, J. Blake Bartlett, Jessica Vermeulen, Thomas S. Lin, Paul G. Richardson, Peter Voorhees
Source: Blood Cancer Journal, Vol 12, Iss 4, Pp 1-5 (2022)
Publisher Information: Nature Publishing Group, 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2044-5385
Relation: https://doaj.org/toc/2044-5385
DOI: 10.1038/s41408-022-00653-1
Access URL: https://doaj.org/article/b428bc1646cf491fb069adf05f112f10
Accession Number: edsdoj.b428bc1646cf491fb069adf05f112f10
Database: Directory of Open Access Journals
More Details
ISSN:20445385
DOI:10.1038/s41408-022-00653-1
Published in:Blood Cancer Journal
Language:English